based on 8 analysts
50.00%
Buy
0.00%
Hold
50.00%
Sell
Based on 8 analysts offering long term price targets for Syngene International Ltd. An average target of ₹760.62
Source: S&P Global Market Intelligence
Syngene International Ltd price forecast by 8 analysts
Downside of
High
₹925
Target
₹760.62
Low
₹640
Syngene International Ltd target price ₹760.62, a slight downside of -17.67% compared to current price of ₹923.85. According to 8 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Syngene International Ltd revenue growth forecast
Expected growth rate Q1, FY2026:28.20%
Forecast
Actual
Including amortisation and stock based compensations
Syngene International Ltd EPS growth forecast
EPS estimate Q1, FY2026:33.25%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 13.25 % |
3 Month Return | + 30.66 % |
1 Year Return | + 11.02 % |
Market Stats | |
Previous Close | ₹917.15 |
Open | ₹917.15 |
Volume | 3.43L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹36,918.68Cr |
P/E Ratio | 75.29 |
PEG Ratio | 259.63 |
Market Cap | ₹36,918.68 Cr |
P/B Ratio | 6.73 |
EPS | 12.69 |
Dividend Yield | 0.18 |
Sector | Healthcare |
ROE | 11.95 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
HOLD | ₹36,918.68 Cr | 38.26% | 0.56 | ₹510 Cr | ₹3,488 Cr | |
BUY | ₹16,634.57 Cr | 4.32% | 0.52 | ₹602 Cr | ₹2,851 Cr | |
BUY | ₹91,491.38 Cr | 29.24% | 0.56 | ₹3,168 Cr | ₹29,001 Cr | |
HOLD | ₹1,12,708.27 Cr | 72.33% | 0.64 | ₹3,854 Cr | ₹19,547 Cr | |
BUY | ₹63,092.63 Cr | 40.15% | 0.53 | NA | NA |
Organisation | Syngene International Ltd |
Headquarters | |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Syngene International Ltd
Shaw highlights the Biosecure Act's potential to shift business from Chinese firms to Indian pharma, benefiting Syngene with a 50% increase in RFPs and strong long-term contracts.
Syngene Expands Supply Chain Amid Demand Surge - 10 Sep, 2024
Syngene International is expanding its supply chain options to reduce reliance on China, reporting a 50% increase in RFPs. Despite a 19% dip in PAT, the stock rose 3.97%. Analysts note strong traction from long-term contracts with multinationals.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, SYNGENE stock has moved up by 3.3%
MF Holding Up
Mutual Funds have increased holdings from 12.59% to 13.63% in Jun 2024 quarter
Against Peers
In the last 3 years, Shree Ganesh Remedies Ltd has given 134.4% return, outperforming this stock by 95.9%
Against Peers
In the last 1 year, Shree Ganesh Remedies Ltd has given 72.7% return, outperforming this stock by 61.6%
Profit Down
Netprofit is down for the last 2 quarters, 188.6 Cr → 75.7 Cr (in ₹), with an average decrease of 59.9% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 20.92% to 20.63% in Jun 2024 quarter
Retail Holding Down
Retail Investor have decreased holdings from 8.17% to 7.42% in Jun 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 54.79% to 54.72% in Jun 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 933.0 Cr → 839.8 Cr (in ₹), with an average decrease of 10.0% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 54.72% | ||
Foreign Institutions | 20.63% | ||
Mutual Funds | 13.63% | 8.29 | |
Retail Investors | 7.42% | ||
Others | 3.59% | 2.05 |
Syngene International Ltd in the last 5 years
Lowest (23.09x)
March 31, 2020
Today (75.29x)
September 13, 2024
Industry (96.83x)
September 13, 2024
Highest (75.44x)
September 10, 2024
Syngene International Ltd’s net profit fell -18.95% since last year same period to ₹75.70Cr in the Q1 2024-2025. On a quarterly growth basis, Syngene International Ltd has generated -59.86% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Syngene International Ltd has declared dividend of ₹1.25 - translating a dividend yield of 0.27%.
Read More about DividendsBearish
Neutral
Bullish
Syngene International Ltd is currently in a Bullish trading position according to technical analysis indicators.
Syngene International Ltd (SYNGENE) share price today is ₹923.85
Syngene International Ltd is listed on NSE
Syngene International Ltd is listed on BSE
PE Ratio of Syngene International Ltd is 75.29
PE ratio = Syngene International Ltd Market price per share / Syngene International Ltd Earnings per share
Today’s traded volume of Syngene International Ltd(SYNGENE) is 3.43L.
Today’s market capitalisation of Syngene International Ltd(SYNGENE) is ₹36918.68Cr.
Syngene International Ltd(SYNGENE | Price |
---|---|
52 Week High | ₹938 |
52 Week Low | ₹607.65 |
Syngene International Ltd(SYNGENE) share price is ₹923.85. It is down -1.51% from its 52 Week High price of ₹938
Syngene International Ltd(SYNGENE) share price is ₹923.85. It is up 52.04% from its 52 Week Low price of ₹607.65
Syngene International Ltd(SYNGENE | Returns |
---|---|
1 Day Returns | 6.7% |
1 Month Returns | 13.25% |
3 Month Returns | 30.66% |
1 Year Returns | 11.02% |